A University of Houston scientist is working to develop the next generation of prostate cancer therapies targeted at metabolism. Daniel Frigo is looking at a cascade of biochemical reactions inside the cell, focusing on an enzyme considered a master regulator of metabolism. Frigo wants to unlock more effective and less harmful treatments. Funded by the Department of Defense and National Institutes of Health, he most recently received another grant last week from Golfers Against Cancer.
Fuente : http://www.eurekalert.org/pub_releases/2014-02/uoh...
Fuente : http://www.eurekalert.org/pub_releases/2014-02/uoh...